Ulf Kahlert

The consortium leader Kahlert is an expert in translational cancer research, with renowned expertise in disease modelling, identification of biomarkers for prognostic diagnostics of as therapeutic targets, as well as in assay development for validation of new drugs´ anti-cancer stem cell potential. He leads the translational research department in high volume surgery clinic enabling large access to patient material that is provided for this study (target discovery and co-clinical validation). Work flow for patient material recruitment and co-clinical trial studies are established.